Glutaminyl Cyclase, Diseases, and Development of Glutaminyl

IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes

An overview of glutaminyl cyclase inhibitors for Alzheimer's disease

Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design - ScienceDirect

Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells

Glutaminyl cyclase expression and pE-A in Alzheimer's disease

A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies

PDF) Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients

Schematic drawing of QC inhibitor approach. pGlu-Aβ

The First Potent Inhibitors for Human Glutaminyl Cyclase: Synthesis and Structure−Activity Relationship

Glutaminyl cyclase - Proteopedia, life in 3D

IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes

Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease—Studies on Relation to Effective Target Occupancy

Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease - Xu - 2021 - ChemistryOpen - Wiley Online Library